FPR2/ALX (fprs1_mouse)

FAMILY

Class A (Rhodopsin) Peptide receptors Formylpeptide receptors FPR2/ALX

GENE

Fpr-s1 (Fpr2, Fpr3, Fprl1, Lxa4r)

ORGANISM

Mouse (Mus musculus)

ALT. NAMES

Formyl peptide receptor-related sequence 1, FMLP-related receptor I, FMLP-R-I, Formyl peptide receptor related sequence 1, Formyl peptide receptor-like 1, Lipoxin A4 receptor, LXA4 receptor, N-formyl peptide receptor 2, N-formyl peptide receptor 3

SOURCE

SWISSPROT

SEQUENCE

N-term        
M
E
T
N
Y
S
I
P
L
N
10
                   
G
S
D
V
V
I
Y
D
S
T
20
TM1              
I
S
R
V
L
W
I
L
S
M
30
                   
V
V
V
S
I
T
F
F
L
G
40
                   
V
L
G
N
G
L
V
I
W
V
50
          ICL1 TM2
A
G
F
R
M
P
H
T
V
T
60
               
T
I
W
Y
L
N
L
A
L
A
70
                   
D
F
S
F
T
A
T
L
P
F
80
                   
L
L
V
E
M
A
M
K
E
K
90
ECL1 TM3      
W
P
F
G
W
F
L
C
K
L
100
                   
V
H
I
A
V
D
V
N
L
F
110
                   
G
S
V
F
L
I
A
V
I
A
120
                   
L
D
R
C
I
C
V
L
H
P
130
ICL2       TM4
V
W
A
Q
N
H
R
T
V
S
140
                   
L
A
R
N
V
V
V
G
S
W
150
                   
I
F
A
L
I
L
T
L
P
L
160
        ECL2    
F
L
F
L
T
T
V
R
D
A
170
                   
R
G
D
V
H
C
R
L
S
F
180
          TM5    
V
S
W
G
N
S
V
E
E
R
190
                   
L
N
T
A
I
T
F
V
T
T
200
                   
R
G
I
I
R
F
I
V
S
F
210
                   
S
L
P
M
S
F
V
A
I
C
220
                   
Y
G
L
I
T
T
K
I
H
K
230
    ICL3 TM6  
K
A
F
V
N
S
S
R
P
F
240
                   
R
V
L
T
G
V
V
A
S
F
250
                   
F
I
C
W
F
P
F
Q
L
V
260
                   
A
L
L
G
T
V
W
L
K
E
270
ECL3     TM7  
M
Q
F
S
G
S
Y
K
I
I
280
                   
G
R
L
V
N
P
T
S
S
L
290
                   
A
F
F
N
S
C
L
N
P
I
300
          H8      
L
Y
V
F
M
G
Q
D
F
Q
310
                   
E
R
L
I
H
S
L
S
S
R
320
C-term        
L
Q
R
A
L
S
E
D
S
G
330
                   
H
I
S
D
T
R
T
N
L
A
340
                   
S
L
P
E
D
I
E
I
K
A
350
 
I

LINKS

ChEMBL

Guide To Pharmacology

UniProt

DIAGRAMS

ICL1 P H ICL1ECL1 E K W P F ECL1ICL2 P V W A Q N H R ICL2ECL2 T T V R D A R G D V H C R L S F V S W G N ECL2ICL3 F V N S ICL3ECL3 L K E M Q F S G S ECL3N-term M E T N Y S I P L N G S D V V I Y D N-termC-term S S R L Q R A L S E D S G H I S D T R T N L A S L P E D I E I K A I C-term S T I S R V L W I L S M V V V S I T F F L G V L G N G L V I W V A G F R M T V T T I W Y L N L A L A D F S F T A T L P F L L V E M A M K G W F L C K L V H I A V D V N L F G S V F L I A V I A L D R C I C V L H T V S L A R N V V V G S W I F A L I L T L P L F L F L S V E E R L N T A I T F V T T R G I I R F I V S F S L P M S F V A I C Y G L I T T K I H K K A S R P F R V L T G V V A S F F I C W F P F Q L V A L L G T V W Y K I I G R L V N P T S S L A F F N S C L N P I L Y V F M G Q D L I H F Q E R S L
Pick color:
 
 
 
 
 
 
 
 
 
 
 
 




Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A

G N G L V G L F F T I S V V V M S L I W 1 L N L A L A D F S F T A T L P F L L V E 2 V A I L F V S G F L N V D V A I H V L K 3 A R N V V V G S W I F A L I L T L P L 4 Y C I A V F S M P L S F S V I F R I I G R 5 T G V V A S F F I C W F P F Q L V A L L 6 I P N L C S N F F A L S S T P N V L R 7
Pick color:
 
 
 
 
 
 
 
 
 
 
 
 




Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A

MUTATIONS

0 mutation data points available.

ENDOGENOUS LIGANDS

No endogenous ligands available

STRUCTURE MODELS

No structure models available. Check the Archive on Structure models for earlier releases.

STRUCTURES

No structures available